Recruiting OBSERVATIONAL NCT06249555

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study (VOICE)

VOICE-Characterization of Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease Using Patient-Reported Outcome Measures: A Prospective Observational Study

Sponsor: Alimentiv Inc.

Conditions Crohn's Disease

Interventions Guselkumab (GUS) Mirikizumab (MIR) Risankizumab (RISA) Ustekinumab (UST) Vedolizumab (VDZ)

Updated 8 times since 2024 Last updated: Feb 11, 2026 Started: Mar 20, 2024 Primary completion: Jun 30, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Crohn's Disease and is currently actively recruiting participants. Alimentiv Inc. leads this study, which shows 8 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Sep 2025 — Feb 2026 [monthly]

Recruiting
Mar 2025 — Sep 2025 [monthly]

Recruiting
Feb 2025 — Mar 2025 [monthly]

Recruiting
Nov 2024 — Feb 2025 [monthly]

Recruiting

▶ Show 3 earlier versions

Sep 2024 — Nov 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Mar 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alimentiv Inc.
Takeda

Data source: Alimentiv Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bellevue, United States , Brampton, Canada , Chapel Hill, United States , Chestnut Hill, United States , Cleveland, United States , Edmonton, Canada , Evanston, United States , Fort Worth, United States , Hamilton, Canada , Iowa City, United States and 13 more locations